Published in Pflugers Arch on January 12, 2010
Ligand-activated PPARδ modulates the migration and invasion of melanoma cells by regulating Snail expression. Am J Cancer Res (2014) 0.79
A novel cell-penetrating peptide derived from WT1 enhances p53 activity, induces cell senescence and displays antimelanoma activity in xeno- and syngeneic systems. FEBS Open Bio (2014) 0.78
Fatty Acids of CLA-Enriched Egg Yolks Can Induce Transcriptional Activation of Peroxisome Proliferator-Activated Receptors in MCF-7 Breast Cancer Cells. PPAR Res (2017) 0.75
Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol (2001) 9.68
Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature (1992) 6.69
AMPK and PPARdelta agonists are exercise mimetics. Cell (2008) 6.39
Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome. Proc Natl Acad Sci U S A (2003) 4.03
Brief, high-temperature heat denaturation (pressure cooking): a simple and effective method of antigen retrieval for routinely processed tissues. J Pathol (1994) 3.44
An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor. Cell (1990) 3.02
Peroxisome proliferator-activated receptor delta controls muscle development and oxidative capability. FASEB J (2003) 2.80
Impaired skin wound healing in peroxisome proliferator-activated receptor (PPAR)alpha and PPARbeta mutant mice. J Cell Biol (2001) 2.41
Increased expression of stem cell markers in malignant melanoma. Mod Pathol (2006) 2.39
Critical roles of PPAR beta/delta in keratinocyte response to inflammation. Genes Dev (2001) 2.32
The many facets of the Wilms' tumour gene, WT1. Hum Mol Genet (2006) 2.10
cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor. Biochemistry (1993) 2.03
Cutaneous malignant melanoma in Europe. Eur J Cancer (2004) 1.88
Nuclear receptors PPARbeta/delta and PPARalpha direct distinct metabolic regulatory programs in the mouse heart. J Clin Invest (2007) 1.88
Cloning of a protein that mediates transcriptional effects of fatty acids in preadipocytes. Homology to peroxisome proliferator-activated receptors. J Biol Chem (1995) 1.88
Coronary vessel development requires activation of the TrkB neurotrophin receptor by the Wilms' tumor transcription factor Wt1. Genes Dev (2005) 1.60
Expression of the neuroectodermal intermediate filament nestin in human melanomas. Cancer Res (1994) 1.58
WT1 interacts with the splicing factor U2AF65 in an isoform-dependent manner and can be incorporated into spliceosomes. Genes Dev (1998) 1.50
Peroxisome proliferator-activated receptor alpha activation decreases metastatic potential of melanoma cells in vitro via down-regulation of Akt. Clin Cancer Res (2006) 1.49
Peroxisome proliferator-activated receptors (PPARs) in skin health, repair and disease. Biochim Biophys Acta (2007) 1.41
Ligand activation of peroxisome proliferator-activated receptor beta inhibits colon carcinogenesis. Cancer Res (2006) 1.40
PPARgamma influences susceptibility to DMBA-induced mammary, ovarian and skin carcinogenesis. Carcinogenesis (2004) 1.38
Melanoma risk in relation to height, weight, and exercise (United States). Cancer Causes Control (2001) 1.35
Peroxisome proliferator-activated receptor-beta/delta inhibits epidermal cell proliferation by down-regulation of kinase activity. J Biol Chem (2005) 1.34
The paired-box transcription factor, PAX2, positively modulates expression of the Wilms' tumor suppressor gene (WT1). Oncogene (1996) 1.31
Diagnosis and treatment of cutaneous melanoma: state of the art 2006. Melanoma Res (2007) 1.27
The Wilms' tumour protein (WT1) shuttles between nucleus and cytoplasm and is present in functional polysomes. Hum Mol Genet (2003) 1.26
Oxygen-regulated expression of the Wilms' tumor suppressor Wt1 involves hypoxia-inducible factor-1 (HIF-1). FASEB J (2003) 1.13
Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) ligands inhibit growth of UACC903 and MCF7 human cancer cell lines. Toxicology (2007) 1.09
Inhibition of melanoma metastases by fenofibrate. Arch Dermatol Res (2004) 1.08
The risk for cutaneous malignant melanoma, melanoma in situ and intraocular malignant melanoma in relation to tobacco use and body mass index. Br J Dermatol (2007) 1.07
The Wilms' tumour suppressor WT1 is involved in endothelial cell proliferation and migration: expression in tumour vessels in vivo. Oncogene (2008) 1.06
Intermediate filament protein nestin is expressed in developing kidney and heart and might be regulated by the Wilms' tumor suppressor Wt1. Am J Physiol Regul Integr Comp Physiol (2006) 1.05
The current epidemiology of cutaneous malignant melanoma. Front Biosci (2006) 1.05
Alterations of peroxisome proliferator-activated receptor delta activity affect fatty acid-controlled adipose differentiation. J Biol Chem (2000) 1.00
Peroxisome proliferator-activated receptor beta stimulation induces rapid cardiac growth and angiogenesis via direct activation of calcineurin. Cardiovasc Res (2009) 0.95
Differential expression of peroxisome proliferator-activated receptors (PPARs) in the developing human fetal digestive tract. J Histochem Cytochem (2000) 0.94
Activators of peroxisome proliferator-activated receptor-alpha partially inhibit mouse skin tumor promotion. Mol Carcinog (2000) 0.93
PAX 8 regulates human WT1 transcription through a novel DNA binding site. J Biol Chem (1997) 0.92
Role of zyxin in differential cell spreading and proliferation of melanoma cells and melanocytes. J Invest Dermatol (2002) 0.92
PPARalpha/gamma expression and activity in mouse and human melanocytes and melanoma cells. Pharm Res (2008) 0.89
The Wilms' tumor suppressor WT1 is associated with melanoma proliferation. Pflugers Arch (2007) 0.88
Activation of the WT1 tumor suppressor gene promoter by Pea3. FEBS Lett (2004) 0.88
Agonists of peroxisome proliferator-activated receptor gamma inhibit cell growth in malignant melanoma. J Invest Dermatol (2002) 0.88
Expression and function of peroxisome proliferator-activated receptors in human melanocytes. Br J Dermatol (2004) 0.84
Melanoma: what are the gaps in our knowledge. PLoS Med (2008) 0.84
Activation of the wt1 Wilms' tumor suppressor gene by NF-kappaB. Oncogene (1998) 0.82
The AMP-activated protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivity. J Clin Invest (2003) 4.11
Application of a filtration- and isolation-by-size technique for the detection of circulating tumor cells in cutaneous melanoma. J Invest Dermatol (2010) 3.26
BRAF/NRAS mutation frequencies among primary tumors and metastases in patients with melanoma. J Clin Oncol (2012) 2.41
Pigmented Bowen's disease mimicking cutaneous melanoma: clinical and dermoscopic aspects. Dermatol Surg (2004) 2.29
RNA induction and inheritance of epigenetic cardiac hypertrophy in the mouse. Dev Cell (2008) 2.23
Cigarette smoke-induced neurogenic inflammation is mediated by alpha,beta-unsaturated aldehydes and the TRPA1 receptor in rodents. J Clin Invest (2008) 2.20
Developmental control of nuclear size and shape by Kugelkern and Kurzkern. Curr Biol (2006) 2.07
Comparison of tumor response by Response Evaluation Criteria in Solid Tumors (RECIST) and modified RECIST in patients treated with sorafenib for hepatocellular carcinoma. Cancer (2011) 2.07
Discovery and characterization of vicriviroc (SCH 417690), a CCR5 antagonist with potent activity against human immunodeficiency virus type 1. Antimicrob Agents Chemother (2005) 2.07
Brain glucagon-like peptide-1 increases insulin secretion and muscle insulin resistance to favor hepatic glycogen storage. J Clin Invest (2005) 2.01
The miR-124-Sox9 paramutation: RNA-mediated epigenetic control of embryonic and adult growth. Development (2009) 1.83
Dermoscopy improves accuracy of primary care physicians to triage lesions suggestive of skin cancer. J Clin Oncol (2006) 1.81
Liver adenosine monophosphate-activated kinase-alpha2 catalytic subunit is a key target for the control of hepatic glucose production by adiponectin and leptin but not insulin. Endocrinology (2006) 1.81
The link between nutritional status and insulin sensitivity is dependent on the adipocyte-specific peroxisome proliferator-activated receptor-gamma2 isoform. Diabetes (2005) 1.76
MC1R variants increase risk of melanomas harboring BRAF mutations. J Invest Dermatol (2008) 1.72
Estrogen receptor expression in cutaneous melanoma: a real-time reverse transcriptase-polymerase chain reaction and immunohistochemical study. Arch Dermatol (2009) 1.67
The Wilms' tumor suppressor Wt1 is expressed in the coronary vasculature after myocardial infarction. FASEB J (2002) 1.54
Fluorescence in situ hybridization, a diagnostic aid in ambiguous melanocytic tumors: European study of 113 cases. Mod Pathol (2010) 1.52
Reliability and validity of the Sedentary Behavior Questionnaire (SBQ) for adults. J Phys Act Health (2010) 1.48
Circulating benign nevus cells detected by ISET technique: warning for melanoma molecular diagnosis. Arch Dermatol (2010) 1.46
Clinically and dermoscopically featureless melanoma: when prevention fails. J Am Acad Dermatol (2002) 1.41
Cytology of peritoneal leishmaniasis in a patient with AIDS. Acta Cytol (2003) 1.38
Partial gene deletion of endothelial nitric oxide synthase predisposes to exaggerated high-fat diet-induced insulin resistance and arterial hypertension. Diabetes (2004) 1.38
The role of estrogens in melanoma and skin cancer. Carcinogenesis (2009) 1.38
Tumor lymphangiogenesis in head and neck squamous cell carcinoma: a morphometric study with clinical correlations. Cancer (2004) 1.35
Dermoscopy for "true" amelanotic melanoma: a clinical dermoscopic-pathologic case study. J Am Acad Dermatol (2006) 1.33
Oxytocin controls differentiation of human mesenchymal stem cells and reverses osteoporosis. Stem Cells (2008) 1.32
Scoring of collagen organization in healthy and diseased human dermis by multiphoton microscopy. J Biophotonics (2010) 1.30
Sinonasal undifferentiated carcinoma, nasopharyngeal-type undifferentiated carcinoma, and keratinizing and nonkeratinizing squamous cell carcinoma express different cytokeratin patterns. Am J Surg Pathol (2002) 1.27
Rapid active zone remodeling during synaptic plasticity. J Neurosci (2011) 1.24
Antibody to a conserved antigenic target is protective against diverse prokaryotic and eukaryotic pathogens. Proc Natl Acad Sci U S A (2013) 1.23
Vulvar basal cell carcinoma: retrospective study and review of literature. Gynecol Oncol (2005) 1.23
Beclin 1 and LC3 autophagic gene expression in cutaneous melanocytic lesions. Hum Pathol (2009) 1.22
Peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) acts as regulator of metabolism linked to multiple cellular functions. Pharmacol Ther (2009) 1.19
Melanomas that failed dermoscopic detection: a combined clinicodermoscopic approach for not missing melanoma. Dermatol Surg (2007) 1.17
Cytotoxic/natural killer cell cutaneous lymphomas. Report of EORTC Cutaneous Lymphoma Task Force Workshop. Cancer (2003) 1.15
New-onset psoriatic palmoplantaris pustulosis following infliximab therapy: a class effect? J Rheumatol (2007) 1.15
Oxygen-regulated expression of the Wilms' tumor suppressor Wt1 involves hypoxia-inducible factor-1 (HIF-1). FASEB J (2003) 1.13
The Wilms' tumor gene Wt1 is required for normal development of the retina. EMBO J (2002) 1.13
The complex life of WT1. J Cell Sci (2003) 1.13
Miz1 is required to maintain autophagic flux. Nat Commun (2013) 1.12
Dermoscopy in pigmented squamous cell carcinoma. J Cutan Med Surg (2009) 1.10
Images in clinical medicine. Plantar melanoma--a false vegetant wart. N Engl J Med (2006) 1.09
Increase in FOXP3+ regulatory T cells in GVHD skin biopsies is associated with lower disease severity and treatment response. Biol Blood Marrow Transplant (2009) 1.07
Characterization of the long pentraxin PTX3 as a TNFalpha-induced secreted protein of adipose cells. J Lipid Res (2003) 1.05
False "melanocytic" parameters shown by pigmented seborrheic keratoses: a finding which is not uncommon in dermoscopy. Dermatol Surg (2002) 1.04
GLUT4, AMP kinase, but not the insulin receptor, are required for hepatoportal glucose sensor-stimulated muscle glucose utilization. J Clin Invest (2003) 1.01
Inducible nitric oxide synthase activity correlates with lymphangiogenesis and vascular endothelial growth factor-C expression in head and neck squamous cell carcinoma. J Pathol (2006) 1.00
Reliability and validity of brief psychosocial measures related to dietary behaviors. Int J Behav Nutr Phys Act (2010) 0.99
Keratinocyte dysfunction in vitiligo epidermis: cytokine microenvironment and correlation to keratinocyte apoptosis. Histol Histopathol (2009) 0.98
BRAFV600E detection in melanoma is highly improved by COLD-PCR. Clin Chim Acta (2011) 0.98
Protease-activated receptor 1-selective antagonist SCH79797 inhibits cell proliferation and induces apoptosis by a protease-activated receptor 1-independent mechanism. Basic Clin Pharmacol Toxicol (2007) 0.97
β-adrenoceptors are upregulated in human melanoma and their activation releases pro-tumorigenic cytokines and metalloproteases in melanoma cell lines. Lab Invest (2013) 0.97
Emerging role of Notch signaling in epidermal differentiation and skin cancer. Cancer Biol Ther (2009) 0.97
Chemokine receptor CCR-5 inhibitors produced by Chaetomium globosum. J Nat Prod (2006) 0.97
Multiparametric analysis of cell-free DNA in melanoma patients. PLoS One (2012) 0.97
Circulating cell-free DNA in plasma of melanoma patients: qualitative and quantitative considerations. Clin Chim Acta (2011) 0.96
Immediate local and regional recurrence after the excision of a polypoid melanoma: tumor dormancy or tumor activation? Dermatol Surg (2003) 0.96
Tissue prognostic biomarkers in primary cutaneous melanoma. Virchows Arch (2014) 0.96
Spectral morphological analysis of skin lesions with a polarization multispectral dermoscope. Opt Express (2013) 0.96
Keratinocyte growth factor receptors. Dermatol Clin (2007) 0.95
Peroxisome proliferator-activated receptor beta stimulation induces rapid cardiac growth and angiogenesis via direct activation of calcineurin. Cardiovasc Res (2009) 0.95
Telomere protection and TRF2 expression are enhanced by the canonical Wnt signalling pathway. EMBO Rep (2013) 0.95
Perception of direct-to-consumer genetic testing and direct-to-consumer advertising of genetic tests among members of a large managed care organization. J Genet Couns (2012) 0.94
Histopathology report of cutaneous melanoma and sentinel lymph node in Europe: a web-based survey by the Dermatopathology Working Group of the European Society of Pathology. Virchows Arch (2009) 0.93
Giant melanoma displaying gross features reproducing parameters seen on dermoscopy. Dermatol Surg (2002) 0.93
Dermoscopic features of mucosal melanosis. Dermatol Surg (2004) 0.93
Expression of Notch-1 and alteration of the E-cadherin/beta-catenin cell adhesion complex are observed in primary cutaneous neuroendocrine carcinoma (Merkel cell carcinoma). Mod Pathol (2009) 0.92
Involvement of cholecystokinin 2 receptor in food intake regulation: hyperphagia and increased fat deposition in cholecystokinin 2 receptor-deficient mice. Endocrinology (2006) 0.92
Thin melanoma of the vulva: a clinical, dermoscopic-pathologic case study. Arch Dermatol (2005) 0.92
Heterogeneous distribution of BRAF/NRAS mutations among Italian patients with advanced melanoma. J Transl Med (2013) 0.92
Superficial cutaneous leiomyosarcoma: a rare, misleading tumor. Am J Clin Dermatol (2008) 0.91
In vivo characterization of the inflammatory infiltrate and apoptotic status in imiquimod-treated basal cell carcinoma. Int J Dermatol (2009) 0.91
Impaired glucose homeostasis in mice lacking the alpha1b-adrenergic receptor subtype. J Biol Chem (2003) 0.91
Possible histopathologic correlates of dermoscopic features in pigmented melanocytic lesions identified by means of optical coherence tomography. Exp Dermatol (2005) 0.90
Bullous pilomatricoma: a particular and rare dermal bullous disorder. Acta Derm Venereol (2009) 0.90
Long-term treatment with lopinavir-ritonavir induces a reduction in peripheral adipose depots in mice. Antimicrob Agents Chemother (2006) 0.90
Application of optical coherence tomography in non-invasive characterization of skin vascular lesions. Skin Res Technol (2008) 0.90
In vivo non-invasive monitoring of collagen remodelling by two-photon microscopy after micro-ablative fractional laser resurfacing. J Biophotonics (2013) 0.90
Dilation of intercellular spaces is associated with laryngo-pharyngeal reflux: an ultrastructural morphometric analysis of laryngeal epithelium. Eur Arch Otorhinolaryngol (2007) 0.90
Sch 213766, a novel chemokine receptor CCR-5 inhibitor from Chaetomium globosum. J Antibiot (Tokyo) (2007) 0.89
An inducible mouse model for PAX2-dependent glomerular disease: insights into a complex pathogenesis. Curr Biol (2006) 0.89
Frequent loss of expression of the cyclin-dependent kinase inhibitor p27(Kip1) in estrogen-related Endometrial adenocarcinomas. Clin Cancer Res (2003) 0.89
Substance P released by TRPV1-expressing neurons produces reactive oxygen species that mediate ethanol-induced gastric injury. Free Radic Biol Med (2007) 0.89
Ventilator modes and settings during non-invasive ventilation: effects on respiratory events and implications for their identification. Thorax (2010) 0.89
Features of regression in dermoscopic diagnosis: a confounding factor? Two clinical, dermoscopic-pathologic case studies. Dermatol Surg (2006) 0.88
The Wilms' tumor suppressor WT1 is associated with melanoma proliferation. Pflugers Arch (2007) 0.88
The Wilms tumor suppressor Wt1 promotes cell adhesion through transcriptional activation of the alpha4integrin gene. J Biol Chem (2006) 0.88
CDX-2 homeobox gene expression. Am J Surg Pathol (2003) 0.88
Germ cells and fatty acids induce translocation of CD36 scavenger receptor to the plasma membrane of Sertoli cells. J Cell Sci (2005) 0.88
Paraganglioma of the nasal cavity: a case report. Eur Arch Otorhinolaryngol (2003) 0.88
Features of small melanocytic lesions: does small mean benign? A clinical-dermoscopic study. Melanoma Res (2012) 0.88
Sebaceous carcinoma arising from nevus sebaceus: a case report. Dermatol Surg (2003) 0.87
Hyalinizing spindle cell tumor with giant rosettes and low-grade fibromyxoid sarcoma: an immunohistochemical and ultrastructural comparative investigation. Ultrastruct Pathol (2004) 0.87
Estrogens, estrogen receptors and melanoma. Expert Rev Anticancer Ther (2011) 0.87
Brief physical activity-related psychosocial measures: reliability and construct validity. J Phys Act Health (2011) 0.86
The Wilms' tumor suppressor Wt1 encodes a transcriptional activator of the class IV POU-domain factor Pou4f2 (Brn-3b). Gene (2003) 0.85
Cutaneous pseudolymphoma localized to black tattoo. J Am Acad Dermatol (2011) 0.85